President Trump's Operation Warp Speed, with its promise of a coronavirus vaccine by the end of the year, is a lofty goal. To me, it is cruel. Only a vaccine can put an end to the virus' grip on our world. To make this promise on that timeline is obviously just a political move. For those of us who are older than 60 years, have children we haven't seen in two months and are afraid to leave our houses, this may really be the ultimate hoax.
Responding to the letter about Democrats in cities doing nothing for minorities for decades, it is by design. The Democrats do not want a vibrant, well-educated middle class. They want dependency on government that breeds a steady stream of voters. If someone becomes dependent on no one, they become mobile and can vote with their feet, and leave the Democrat control of their lives. Democrats want you dependent on them, thats the bottom line.
American democracy has been chained by the right and hijacked by the left. Middle America has been hoodwinked by upper-class elitists on both sides. Right-wing conservatives led by the top 2% super-rich have snookered the working class into believing that there is no difference between economic, religious or cultural conservative idealism. Left-wing academic, artsy and so-called progressive elitists have teamed with the media creating a massively profitable industrial complex feeding off the latest righteous crusades. The elites continue enriching themselves at the middles expense. Dont let the elites on either side crush our backbone. Stand up and fight for Middle America.
Independent Patriot
A Black national anthem and a white national anthem to be played at the start of the National Football Leagues first game? Really? This will do nothing but emphasize our differences rather than promote togetherness. I want an anthem that points out our weaknesses but yet strives for greatness. I want an anthem that explains fighting for the right to make all men equal not just in an hour of need but always. I want an anthem I can appreciate, that speaks for everyone, that all people would be proud to stand for.
After cancellation by the American Legion, it is inspiring to see the teams find a way to still play ball. They applied good old American ingenuity have a problem, find a way to fix it. They have banded together to play 33 games. There will be those who disapprove but what could be safer than healthy young men playing ball in the fresh air. Good luck to the Berks Independent Baseball League.
Proud to be an American
Seniors don't forget what you were promised from those you elected. They lied, you are still paying property taxes and you will lose your home. Make your vote count.
Night light
President Obama acknowledged on multiple occasions that he did not have the authority to unilaterally alter immigration law, yet its exactly what he did when he implemented DACA. At some point the courts will rightfully rule DACA unconstitutional as it did with DAPA. Its heartbreaking that the Democrats in Congress refused a very fair deal from President Trump in 2018 to resolve the fate of the Dreamers in exchange for increased border security and real immigration reform. President Trump has been trying to solve the problem, but the Democrats chose to leave the Dreamers in legal limbo just to have a campaign issue.
Robert Minninger
Thank you, Pottstown for having peaceful protests. Some questions for the white folks participating. Do you live in Pottstown? If not, why not? If you do live in Pottstown, what part of town do you live in and why did you choose it? Is it racially diverse? If you're protesting for equality yet going back to your all-white, no-crime neighborhood, you're a hypocrite.
Truth hurts
The inadequate response to the coronavirus in the Oval Office as well as similar actions by governors in states such as Alabama, Arizona, Arkansas and South Carolina (states with the highest rates in the nation when adjusted for population) have increased the coronavirus spread. Wear a mask. Stay safe!
M. Furlong needs to stop playing the name game in order to divert attention from the real issue of racial inequality in this country. The poor use of funds to help people of color can be blamed on both Democrats and Republicans since forever. And until he takes one small step toward impartiality, hell never understand the meaning of Black Lives Matter.
If you havent heard already, Tower Health is closing the Maternity Unit at Pottstown Hospital. The Maternity Unit has provided this community with outstanding care for mothers and their newborns and has provided a multitude of services like birthing classes, baby care classes, breastfeeding classes, car seat checks. Where will these girls go to deliver? Most of them dont have transportation to Reading or Phoenixville. This community is losing a great asset. We all need to contact the hospital, state and local reps and demand they keep this unit open. We need to keep our moms to be and babies safe!
This week's Stay-At-Home readings are: How To Avoid Traffic Tickets by Constance Lee Parks; How To Find Love by Mary Mee; Housecleaning Tips by Mary Maids; Positive Thinking by Will Power
Funnyman
The potential for "One-shot cures" of gene therapy is valid, however, such treatments do not offer recurring revenue like chronic therapies do. While gene therapy is very attractive to patients, it becomes a challenge to doctors of genome medicine looking for sustained cash flow. This should tell you what is most important and which path they'll follow since prescription drugs have made Big Pharma and docs quite wealthy.
Med Tech
Why are school police out and about in district cars when school isnt in session?
Ano Nymous
Should Rep. Houlahan be judged by the company she keeps? Disdain for the military is not a recent Democrat position. To mask this reality in historically Republican districts, Nancy Pelosi recruited former officers for 2018 congressional campaigns. One such candidate was Chrissy Houlahan who became a reliable ally of Rep. Adam Schiff (D-CA) in a seditious, fact-bereft attempt to unseat a president. Last week, Houlahan featured Rep. Karen Bass (D-CA) in a virtual town hall meeting. Who is Bass? An unapologetic radical who lamented the death of "Commandante El Jefe" Fidel Castro.
M. Furlong
Schools do not teach manners, that is the parents' job. What we see today are children with knowledge, sports achievements, different dress codes, anger over everything but no manners or common sense. You, as parents, have failed the youth of today and tomorrow. When an officer of the law says stop, why do children keep running?
Star Light
I'm so glad I got to see Mount Rushmore on television this past weekend because the way things are going, that will be the next thing the protesters want torn down.
I watched the amateur looters on the news dressed in T-shirts and shorts, but the professional looters who steal from us daily dress in suits and ties. They're known as "Congress!"
Jim Fitch
Sound Off is a forum to spur dialogue from residents of the communities The Mercury serves on topics of general interest in those communities and beyond. We will not publish comments that are potentially libelous, slanderous, mean-spirited, vulgar or inappropriate. Publication of Sound Off comments is at the sole discretion of the editor. Email your brief comment to letters@pottsmerc.com. Please use "Sound Off" in the subject line of the email.
See the original post here:
The Mercury's Sound Off for Sunday, July 12 | Opinion - The Mercury
- Patient Dies of Acute Liver Failure After Treatment With Sareptas DMD Gene Therapy Elevidys - CGTLive - March 19th, 2025
- Patient dies following muscular dystrophy gene therapy, Sarepta reports - The Associated Press - March 19th, 2025
- Duchenne patient dies after receiving Sarepta gene therapy - March 19th, 2025
- Liver Failure-Associated Death Reported in Patient Treated With Sarepta Gene Therapy Elevidys - MedCity News - March 19th, 2025
- DoD grant funds Hollings researcher's idea to pursue gene therapy for cancer - Medical University of South Carolina - March 19th, 2025
- Recon: Sarepta reports death of teen who received Duchenne gene therapy; Novartis to slash 427 jobs while revamping cardiovascular business -... - March 19th, 2025
- Data Gaps Leave Long-Term Impact of Ex Vivo Gene Therapy in DMD Uncertain - AJMC.com Managed Markets Network - March 19th, 2025
- CHO Plus Obtains U.S. Patent for Improved Production of Viral Vectors for Gene Therapy - Business Wire - March 19th, 2025
- Sarepta Shares Fall on Report of Patient Death After Gene Therapy - Bloomberg - March 19th, 2025
- Hologen AI commits up to $430M to help take MeiraGTx's Parkinson's gene therapy through phase 3 and beyond - Fierce Biotech - March 19th, 2025
- Duchenne patient on Sareptas gene therapy dies - The Business Journals - March 19th, 2025
- Im Unstoppable: New gene therapy cures first New Yorker of sickle cell anemia - PIX11 New York News - March 19th, 2025
- Boost in cancer treatment: PGI working on lab for stem cell, gene therapies - The Times of India - March 19th, 2025
- Man Cured Of Sickle Cell Disease In New York Thanks To New Gene Therapy - Forbes - March 19th, 2025
- Sarepta says teen died after its gene therapy treatment By Reuters - Investing.com - March 19th, 2025
- Innovative Gene Therapy Approach Drives Buy Rating for Insmed in DMD Treatment - TipRanks - March 19th, 2025
- Sarepta says patient dies after treatment with gene therapy - TradingView - March 19th, 2025
- Sarepta tumbles after patient dies following gene therapy treatment - TradingView - March 19th, 2025
- MeiraGTx teams with cryptic AI startup, co-founded by Eric Schmidt, to advance Parkinson's gene therapy - Endpoints News - March 19th, 2025
- Sickle cell anemia patient reunites with Long Island doctors whose gene therapy treatments made him symptom-free - Newsday - March 19th, 2025
- Extracellular vesicles for the delivery of gene therapy - Nature.com - March 9th, 2025
- Around the Helix: Cell and Gene Therapy Company Updates March 5, 2025 - CGTLive - March 9th, 2025
- Inside the secret island where wealthy people go to alter their DNA - Daily Mail - March 9th, 2025
- Regenerons Gene Therapy DB-OTO Trial Shows Promising Hearing Improvement - The Hearing Review - March 9th, 2025
- Global Cell and Gene Therapy Manufacturing Market to Reach ~USD 10 Billion by 2032 | DelveInsight - GlobeNewswire - March 9th, 2025
- College Station gene therapy company partners with nonprofit to develop treatments for rare diseases - KBTX - March 9th, 2025
- World Hearing Day 2025: Looking Back at Progress in Gene Therapy - CGTLive - March 9th, 2025
- Reflecting on a milestone year for cell and gene therapies - Pharmaceutical Technology - March 9th, 2025
- Q&A: Whats Next for Hemophilia Gene Therapy? | Newswise - Newswise - March 9th, 2025
- 'Llife-changing' gene therapy in London partially restores CT child's sight - CT Insider - March 9th, 2025
- The Genesis of Cell Therapy: Bridging Traditional Pharmacology and Gene Therapy - Technology Networks - March 9th, 2025
- Regenxbio at TD Cowen Conference: Gene Therapy Advancements - Investing.com - March 9th, 2025
- Anova Announces First Patient Enrolled to Phase 1/2a Study of DB107 for the Treatment of High-Grade Gliomas - Business Wire - March 9th, 2025
- Apertura Gene Therapy Supports the Broad Institute in Development of Gene Therapy for Prion Disease Using Engineered AAV Capsid Targeting TfR1 for CNS... - March 9th, 2025
- Gene therapy research offers hope for people with chronic kidney disease - Medical Xpress - January 6th, 2025
- Sangamo Therapeutics to Regain Full Rights to Hemophilia A Gene Therapy Program Following Pfizers Decision to Cease Development of Giroctocogene... - January 6th, 2025
- JCR Pharmaceuticals and Modalis Therapeutics Announce Transition to the Next Phase of Joint Research Agreement for Development of Novel Gene Therapy -... - January 6th, 2025
- Gene therapy targets the retina to treat eye disease - Nature.com - January 6th, 2025
- Sangamos Stock Plummets as Pfizer Axes Hemophilia Gene Therapy Pact - BioSpace - January 6th, 2025
- How Increased Use of Gene Therapy Treatment for Sickle Cell Disease Could Affect the Federal Budget - Congressional Budget Office - January 6th, 2025
- The Future of Regulatory Processes in Cell and Gene Therapy - Pharmaceutical Executive - January 6th, 2025
- CGTLive's 2024 Pillars of Progress: Most-Watched Conference Interviews - CGTLive - January 6th, 2025
- Pfizer cuts losses on near-approval hemophilia gene therapy, adding to troubled Sangamo's woes - Fierce Biotech - January 6th, 2025
- JCR Pharmaceuticals and Modalis Advance Joint Gene Therapy Research - TipRanks - January 6th, 2025
- JCR and Modalis Advance Joint Gene Therapy Research - TipRanks - January 6th, 2025
- Novartis Gene Therapy Shows Promise in Treating SMA - Yahoo Finance - January 6th, 2025
- Gene Therapy Market to Hit Valuation of US$ 42.26 Billion By 2033 | Astute Analytica - Yahoo Finance - January 6th, 2025
- Novartis gene therapy helps children with rare muscle disorder in study - Reuters - January 6th, 2025
- Capricor Puts Rolling BLA for DMD Cardiomyopathy Cell Therapy Deramiocel in Front of the FDA - CGTLive - January 6th, 2025
- Positive data could expand use of Novartis gene therapy for SMA - Yahoo Finance - January 6th, 2025
- Sangamo spirals after Pfizer halts hemophilia A gene therapy partnership - MM+M Online - January 6th, 2025
- Cell Therapy and Gene Therapy CDMO Market to Reach USD 11.11 Billion by 2030 | Discover Growth Trends and Insights | Valuates Reports - PR Newswire - January 6th, 2025
- Struggling With Adoption, Sickle Cell Gene Therapy Manufacturers Embrace CMS Model - News & Insights - January 6th, 2025
- Sangamo Therapeutics to Regain Rights to Gene Therapy Program from Pfizer - Contract Pharma - January 6th, 2025
- Researchers Create Gene Therapy with Potential to Treat Peripheral Pain ... - December 28th, 2024
- How CRISPR Is Changing Cancer Research and Treatment - December 28th, 2024
- Gene Therapy Shows Long-Term Vision Benefits in Rare Eye Disease - December 28th, 2024
- 100 cell and gene therapy leaders to watch in 2025 - December 28th, 2024
- Can a new gene therapy reverse heart failure? - Futurity - December 28th, 2024
- Sustained visual improvements in LHON patients treated with AAV gene therapy - Medical Xpress - December 28th, 2024
- Nebraska Medicine administers novel gene therapy to first hemophilia ... - December 28th, 2024
- Gene Therapy for Cardiomyopathies Presents Promising Alternative to Current Treatment - Managed Healthcare Executive - December 28th, 2024
- Stem Cell Transplantation Still the Main Treatment Option for Beta-Thalassemia - Medpage Today - December 28th, 2024
- Caribou Overhyped Gene-Therapy Testing, Investor Class Suit Says - Bloomberg Law - December 28th, 2024
- WuXi AppTec sells off cell and gene therapy operations in US, UK - FirstWord Pharma - December 28th, 2024
- Top 5 Print Publication Articles of 2024 - Managed Healthcare Executive - December 28th, 2024
- Gene Therapy Shows Long-Term Vision Benefits in Rare Eye Disease - Medpage Today - December 28th, 2024
- UPenn gene therapy pioneers biotech gets $34 million in funding - The Philadelphia Inquirer - December 28th, 2024
- PHC Corporation to present LiCellGrow at Advanced Therapies Week 2025 - Drug Target Review - December 28th, 2024
- The Evolution of Cell & Gene Therapy: Development and Manufacturing Insights and the Role of CDMOs - Pharmaceutical Technology Magazine - December 28th, 2024
- Pig kidney transplants, new schizophrenia drug: Here are 5 of the biggest medical breakthroughs in 2024 - ABC News - December 28th, 2024
- Cell Therapy Manufacturing Trends And Advancements Continuing In 2025 - BioProcess Online - December 28th, 2024
- Can Gene Therapy Treat Chronic Pain? - LabRoots - December 28th, 2024
- Driving innovation: India's foray into gene and cell therapies - The Economic Times - December 28th, 2024
- Governor Hochul Celebrates the Opening Of New York's First Cell and Gene Therapy Hub at Roswell Park Comprehensive Cancer Center in Buffalo - PR Web - December 19th, 2024
- GenSight Biologics Provides Update on Regulatory Discussions and Financial Situation - Business Wire - December 19th, 2024
- Atsena completes dosing in part A of X-linked retinoschisis gene therapy trial - Healio - December 19th, 2024
- Astellas and Sangamo Therapeutics Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases - StreetInsider.com - December 19th, 2024
- Ring Therapeutics lays off just under half of staff in 2nd wave of cuts this year, CEO set to step down - Fierce Biotech - December 19th, 2024
- Gov. Hochul celebrates opening of first cell and gene therapy hub in NYS - WIVB.com - News 4 - December 19th, 2024